4.6 Article

Rapid reduction in hospitalisations after an intervention to manage severe asthma

Journal

EUROPEAN RESPIRATORY JOURNAL
Volume 35, Issue 3, Pages 515-521

Publisher

EUROPEAN RESPIRATORY SOC JOURNALS LTD
DOI: 10.1183/09031936.00101009

Keywords

Asthma; hospitalisation; prevention; treatment

Funding

  1. Fundacao de Amparo a Pesquisa da Bahia (Salvador, Brazil)
  2. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Brasilia, Brazil)
  3. Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brasilia)
  4. Social Change, Asthma and Allergy in Latin America project (Welcome Trust, London, UK)

Ask authors/readers for more resources

Asthma is the third cause of hospitalisations due to clinical illnesses in Brazil. The Programme for Control of Asthma in Bahia (ProAR) leads an initiative in Salvador City (Brazil) to manage severe asthma for free. The aim of this study was to identify trends in asthma hospitalisation in the entire city and to evaluate the impact of ProAR. Information on asthma hospitalisations from 1998 to 2006 was collected. We analysed trends in Salvador (2.8 million inhabitants) before and after ProAR, taking pneumonia and myocardial infarction into account for local comparison. As an external control we obtained information on asthma from Recife, which is the most comparable Brazilian city. In Salvador, asthma hospital admissions declined by 82.3% (1998-2006). A greater proportion of this reduction (74%) occurred after 2003, in parallel with the implementation of ProAR. The reduction in asthma admissions in Recife was smaller. The rates of hospitalisation in 2006 were 2.25 per 10,000 inhabitants in Salvador and 17.06 in Recife. In Salvador, we found an inverse correlation between the provision of medication for asthma and hospitalisation (-0.801; p<0.0001). A rapid reduction in asthma admissions in the entire city of Salvador was associated with ProAR, a public health intervention targeting severe asthma.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available